Although this study suggests that the scattered hypoxic regions in ID1-overexpressing tumors could potentially contribute to AAT resistance, the characteristics of these regions that may confer resistance to cancer cells are not yet comprehensively understood. The gene discussed is ID1; the disease is cancer.